Literature DB >> 19750208

Single cell analysis of complex thymus stromal cell populations: rapid thymic epithelia preparation characterizes radiation injury.

Kirsten M Williams1, Heather Mella, Philip J Lucas, Joy A Williams, William Telford, Ronald E Gress.   

Abstract

Thymic epithelial cells (TECs) and dendritic cells are essential for the maintenance of thymopoiesis. Because these stromal elements define the progenitor niche, provide critical survival signals and growth factors, and direct positive and negative selection, detailed study of these populations is necessary to understand important elements for thymic renewal after cytotoxic injury. Study of TEC is currently hindered by lengthy enzymatic separation techniques with decreased viability. We present a new rapid separation technique that yields consistent viable TEC numbers in a quarter of the prior preparation time. Using this new procedure, we identify changes in stroma populations following total body irradiation (TBI). By flow cytometry, we show that TBI significantly depletes UEA+ medullary TEC, while sparing Ly51+ CD45- cells. Further characterization of the Ly51+ subset reveals enrichment of fibroblasts (CD45- Ly51+ MHCII-), while cortical TECs (CD45- Ly51+ MHCII+) were markedly reduced. Dendritic cells (CD11lc+ CD45+) were also decreased following TBI. These data suggest that cytotoxic preparative regimens may impair thymic renewal by reducing critical populations of cortical and medullary TEC, and that such thymic damage can be assessed by this new rapid separation technique, thereby providing a means of assessing optimal conditioning pretransplantfor enhancing thymic-dependent immune reconstitution posttranspiant.

Entities:  

Keywords:  radiation; separation; thymic epithelial cell

Mesh:

Substances:

Year:  2009        PMID: 19750208      PMCID: PMC2741333          DOI: 10.1111/j.1752-8062.2009.00128.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  46 in total

1.  Analysis of thymic stromal cell populations using flow cytometry.

Authors:  D H D Gray; A P Chidgey; R L Boyd
Journal:  J Immunol Methods       Date:  2002-02-01       Impact factor: 2.303

2.  Critical role for CXCR4 signaling in progenitor localization and T cell differentiation in the postnatal thymus.

Authors:  Jason Plotkin; Susan E Prockop; Ana Lepique; Howard T Petrie
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

3.  A role for CCR9 in T lymphocyte development and migration.

Authors:  Shoji Uehara; Alexander Grinberg; Joshua M Farber; Paul E Love
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

4.  Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches.

Authors:  T M Friedman; G Varadi; D D Hopely; J Filicko; J Wagner; A Ferber; J Martinez; J Brunner; D Grosso; L McGuire; R Korngold; N Flomenberg
Journal:  Biol Blood Marrow Transplant       Date:  2001       Impact factor: 5.742

5.  Stromal cell-derived factor 1/CXCR4 signaling is critical for early human T-cell development.

Authors:  Carmen Hernández-López; Alberto Varas; Rosa Sacedón; Eva Jiménez; Juan José Muñoz; Agustín G Zapata; Angeles Vicente
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

6.  Projection of an immunological self shadow within the thymus by the aire protein.

Authors:  Mark S Anderson; Emily S Venanzi; Ludger Klein; Zhibin Chen; Stuart P Berzins; Shannon J Turley; Harald von Boehmer; Roderick Bronson; Andrée Dierich; Christophe Benoist; Diane Mathis
Journal:  Science       Date:  2002-10-10       Impact factor: 47.728

7.  Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.

Authors:  T Nordøy; A Husebekk; I S Aaberge; P A Jenum; H H Samdal; L B Flugsrud; A C Kristoffersen; H Holte; S Kvaløy; A Kolstad
Journal:  Bone Marrow Transplant       Date:  2001-10       Impact factor: 5.483

Review 8.  The thymus gland: a target organ for growth hormone.

Authors:  W Savino; M C Postel-Vinay; S Smaniotto; M Dardenne
Journal:  Scand J Immunol       Date:  2002-05       Impact factor: 3.487

9.  Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations.

Authors:  Sharon R Lewin; Glenn Heller; Linqi Zhang; Elaine Rodrigues; Eva Skulsky; Marcel R M van den Brink; Trudy N Small; Nancy A Kernan; Richard J O'Reilly; David D Ho; James W Young
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

10.  Nonmyeloablative regimen preserves "niches" allowing for peripheral expansion of donor T-cells.

Authors:  Nelson J Chao; Cong X Liu; Barbara Rooney; Benny J Chen; Gwynn D Long; James J Vredenburgh; Ashley Morris; Cristina Gasparetto; David A Rizzieri
Journal:  Biol Blood Marrow Transplant       Date:  2002       Impact factor: 5.742

View more
  24 in total

1.  Isolation of myeloid dendritic cells and epithelial cells from human thymus.

Authors:  Christina Stoeckle; Ioanna A Rota; Eva Tolosa; Christoph Haller; Arthur Melms; Eleni Adamopoulou
Journal:  J Vis Exp       Date:  2013-09-19       Impact factor: 1.355

Review 2.  Thymic T-cell development in allogeneic stem cell transplantation.

Authors:  Werner Krenger; Bruce R Blazar; Georg A Holländer
Journal:  Blood       Date:  2011-03-22       Impact factor: 22.113

3.  Self-pMHCII complexes are variably expressed in the thymus and periphery independent of mRNA expression but dependent on the activation state of the APCs.

Authors:  Stephanie N Rodriguez; Meizi Jiang; Hideaki Bujo; Paul M Allen
Journal:  Mol Immunol       Date:  2014-10-22       Impact factor: 4.407

4.  Promoting 3-D Aggregation of FACS Purified Thymic Epithelial Cells with EAK 16-II/EAKIIH6 Self-assembling Hydrogel.

Authors:  Asako Tajima; Wen Liu; Isha Pradhan; Suzanne Bertera; Robert A Lakomy; William A Rudert; Massimo Trucco; Wilson S Meng; Yong Fan
Journal:  J Vis Exp       Date:  2016-06-27       Impact factor: 1.355

5.  Chemokine treatment rescues profound T-lineage progenitor homing defect after bone marrow transplant conditioning in mice.

Authors:  Shirley L Zhang; Xinxin Wang; Sugata Manna; Daniel A Zlotoff; Jerrod L Bryson; Bruce R Blazar; Avinash Bhandoola
Journal:  Blood       Date:  2014-05-29       Impact factor: 22.113

6.  FOXN1 compound heterozygous mutations cause selective thymic hypoplasia in humans.

Authors:  Qiumei Du; Larry K Huynh; Fatma Coskun; Erika Molina; Matthew A King; Prithvi Raj; Shaheen Khan; Igor Dozmorov; Christine M Seroogy; Christian A Wysocki; Grace T Padron; Tyler R Yates; M Louise Markert; M Teresa de la Morena; Nicolai Sc van Oers
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

7.  Isolation, identification, and purification of murine thymic epithelial cells.

Authors:  Yan Xing; Kristin A Hogquist
Journal:  J Vis Exp       Date:  2014-08-08       Impact factor: 1.355

8.  Defective selection of thymic regulatory T cells accompanies autoimmunity and pulmonary infiltrates in Tcra-deficient mice double transgenic for human La/Sjögren's syndrome-B and human La-specific TCR.

Authors:  Jane C Yaciuk; Yujun Pan; Karen Schwarz; Zi-Jian Pan; Jacen S Maier-Moore; Stanley D Kosanke; Christina Lawrence; A Darise Farris
Journal:  J Immunol       Date:  2015-01-12       Impact factor: 5.422

9.  Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin.

Authors:  Rahul Palchaudhuri; Borja Saez; Jonathan Hoggatt; Amir Schajnovitz; David B Sykes; Tiffany A Tate; Agnieszka Czechowicz; Youmna Kfoury; Fnu Ruchika; Derrick J Rossi; Gregory L Verdine; Michael K Mansour; David T Scadden
Journal:  Nat Biotechnol       Date:  2016-06-06       Impact factor: 54.908

Review 10.  Thymus: the next (re)generation.

Authors:  Mohammed S Chaudhry; Enrico Velardi; Jarrod A Dudakov; Marcel R M van den Brink
Journal:  Immunol Rev       Date:  2016-05       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.